Inventor
Namita Gandhi
Inventor
New York, NY, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
A61BDiagnosis5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
PatentTitleYear
10,676,530Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor202010,669,341Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor202010,392,439Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor201910,066,017Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist201810,059,771Methods for treating nasal polyposis by administering an IL-4R antagonist20189,574,004'Methods for treating or preventing asthma by administering an IL-4R antagonist'2017Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2017–2020Patents assigned to REGENERON PHARMA (6)· patent assignee history
2017–2018Patents assigned to SANOFI BIOTECHNOLOGY (3)· patent assignee history
2017Patents assigned to SANOFI SA (1)· patent assignee history
2017–2020Based in New York, NY, US· patent location history
2018Based in Tarrytown, NY, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 6 | 2017–2020 |
| SANOFI BIOTECHNOLOGY | 3 | 2017–2018 |
| SANOFI SA | 1 | 2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| New York, New York, US | 5 | 2017–2020 |
| Tarrytown, New York, US | 1 | 2018 |